PubRank

M Korc

Author PubWeight™ 187.41‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Enhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 1993 2.86
2 The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J Clin Invest 1998 2.22
3 Estrogen binding, receptor mRNA, and biologic response in osteoblast-like osteosarcoma cells. Science 1988 2.22
4 Coexpression of epidermal growth factor receptor and ligands in human pancreatic cancer is associated with enhanced tumor aggressiveness. Anticancer Res 1993 2.15
5 Overexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stage. Cancer Res 1993 2.08
6 Overexpression of HER2/neu oncogene in human pancreatic carcinoma. Hum Pathol 1993 2.05
7 Insulin-like growth factor I overexpression in human pancreatic cancer: evidence for autocrine and paracrine roles. Cancer Res 1995 1.89
8 Detection and localization of Mip-3alpha/LARC/Exodus, a macrophage proinflammatory chemokine, and its CCR6 receptor in human pancreatic cancer. Int J Cancer 1999 1.81
9 Action of secretagogues on a new preparation of functionally intact, isolated pancreatic acini. Am J Physiol 1978 1.80
10 Enhanced expression of vascular endothelial growth factor in human pancreatic cancer correlates with local disease progression. Clin Cancer Res 1997 1.74
11 In vivo induction of massive proliferation, directed migration, and differentiation of neural cells in the adult mammalian brain. Proc Natl Acad Sci U S A 2000 1.67
12 The TGF-beta signaling inhibitor Smad7 enhances tumorigenicity in pancreatic cancer. Oncogene 1999 1.63
13 Microarray-based identification of differentially expressed growth- and metastasis-associated genes in pancreatic cancer. Cell Mol Life Sci 2003 1.60
14 KAI1 expression is up-regulated in early pancreatic cancer and decreased in the presence of metastases. Cancer Res 1996 1.59
15 Pancreatic islet-acinar cell interaction: amylase messenger RNA levels ar determined by insulin. Science 1981 1.59
16 Glypican-1 is overexpressed in human breast cancer and modulates the mitogenic effects of multiple heparin-binding growth factors in breast cancer cells. Cancer Res 2001 1.55
17 Enhanced expression of the type II transforming growth factor beta receptor in human pancreatic cancer cells without alteration of type III receptor expression. Cancer Res 1993 1.53
18 Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle. Proc Natl Acad Sci U S A 1987 1.51
19 Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma. Br J Cancer 1997 1.47
20 Enhanced glypican-3 expression differentiates the majority of hepatocellular carcinomas from benign hepatic disorders. Gut 2001 1.46
21 Differential regulation of expression of three transforming growth factor beta species in human breast cancer cell lines by estradiol. Cancer Res 1990 1.45
22 Enhanced expression of the type II transforming growth factor-beta receptor is associated with decreased survival in human pancreatic cancer. Pancreas 1999 1.41
23 A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling. Proc Natl Acad Sci U S A 1994 1.41
24 Nerve growth factor expression correlates with perineural invasion and pain in human pancreatic cancer. J Clin Oncol 1999 1.38
25 Syndecan-1 expression is up-regulated in pancreatic but not in other gastrointestinal cancers. Int J Cancer 2000 1.37
26 Bone morphogenetic protein 2 exerts diverse effects on cell growth in vitro and is expressed in human pancreatic cancer in vivo. Gastroenterology 1999 1.36
27 Aberrant expression of type I fibroblast growth factor receptor in human pancreatic adenocarcinomas. Cancer Res 1993 1.36
28 Nerve growth factor and its high-affinity receptor in chronic pancreatitis. Ann Surg 1999 1.35
29 Connective tissue growth factor is a regulator for fibrosis in human chronic pancreatitis. Ann Surg 1999 1.34
30 Id-1 and Id-2 are overexpressed in pancreatic cancer and in dysplastic lesions in chronic pancreatitis. Am J Pathol 1999 1.33
31 Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer. Proc Natl Acad Sci U S A 1986 1.33
32 Induction and expression of amphiregulin in human pancreatic cancer. Cancer Res 1994 1.32
33 Increased expression of erbB3 in colorectal cancer is associated with concomitant increase in the level of erbB2. Hum Pathol 1998 1.30
34 Concomitant over-expression of vascular endothelial growth factor and its receptors in pancreatic cancer. Int J Cancer 2000 1.30
35 A KrasG12D-driven genetic mouse model of pancreatic cancer requires glypican-1 for efficient proliferation and angiogenesis. Oncogene 2011 1.27
36 Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma. Am J Surg 1999 1.27
37 Induction of platelet-derived growth factor A and B chains and over-expression of their receptors in human pancreatic cancer. Int J Cancer 1995 1.26
38 Enhanced expression of the insulin receptor substrate-2 docking protein in human pancreatic cancer. Cancer Res 1998 1.24
39 Coexpression of the c-met proto-oncogene and hepatocyte growth factor in human pancreatic cancer. Cancer Res 1994 1.23
40 Pancreatic cancer cell-derived vascular endothelial growth factor is biologically active in vitro and enhances tumorigenicity in vivo. Int J Cancer 2001 1.21
41 Enhanced erbB-3 expression in human pancreatic cancer correlates with tumor progression. Clin Cancer Res 1995 1.19
42 Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum. J Clin Invest 1998 1.19
43 Induction and expression of heparin-binding EGF-like growth factor in human pancreatic cancer. Biochem Biophys Res Commun 1994 1.18
44 Increased expression of transforming growth factor beta isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action. Cancer Res 1994 1.18
45 Pancreatic cancer: the potential clinical relevance of alterations in growth factors and their receptors. J Mol Med (Berl) 1996 1.18
46 Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation. Clin Cancer Res 2001 1.16
47 Transforming growth factor beta mediates the progesterone suppression of an epithelial metalloproteinase by adjacent stroma in the human endometrium. Proc Natl Acad Sci U S A 1995 1.13
48 Increased expression of keratinocyte growth factor in human pancreatic cancer. Biochem Biophys Res Commun 1995 1.13
49 bax, but not bcl-2, influences the prognosis of human pancreatic cancer. Gut 1998 1.12
50 Synthesis and expression of transforming growth factor beta-1, beta-2, and beta-3 in the endocrine and exocrine pancreas. Diabetes 1993 1.12
51 Actinomycin D induces apoptosis and inhibits growth of pancreatic cancer cells. Int J Cancer 2000 1.12
52 Increased expression of insulin receptor substrate-1 in human pancreatic cancer. Biochem Biophys Res Commun 1996 1.12
53 Cytosolic calcium regulates epidermal growth factor endocytosis in rat pancreas and cultured fibroblasts. Proc Natl Acad Sci U S A 1984 1.10
54 Enhanced urokinase plasminogen activation in chronic pancreatitis suggests a role in its pathogenesis. Gastroenterology 1997 1.09
55 p53 mutations are common in pancreatic cancer and are absent in chronic pancreatitis. Cancer Lett 1993 1.09
56 Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells. Pancreas 1999 1.08
57 Neurotensin receptor-1 mRNA analysis in normal pancreas and pancreatic disease. Clin Cancer Res 2000 1.08
58 Characterization of cytokeratin 20 expression in pancreatic and colorectal cancer. Clin Cancer Res 1999 1.08
59 Fibroblast growth factor-5 stimulates mitogenic signaling and is overexpressed in human pancreatic cancer: evidence for autocrine and paracrine actions. Oncogene 1997 1.08
60 Differential expression of metastasis-associated genes in papilla of vater and pancreatic cancer correlates with disease stage. J Clin Oncol 2001 1.07
61 Increased expression of transforming growth factor beta s after acute oedematous pancreatitis in rats suggests a role in pancreatic repair. Gut 1997 1.07
62 Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis. Am J Pathol 1994 1.07
63 Inhibition of cyclin D1 expression in human pancreatic cancer cells is associated with increased chemosensitivity and decreased expression of multiple chemoresistance genes. Cancer Res 1999 1.07
64 Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer. Am J Pathol 1998 1.07
65 Epiregulin is Up-regulated in pancreatic cancer and stimulates pancreatic cancer cell growth. Biochem Biophys Res Commun 2000 1.05
66 Overexpression of lymphangiogenic growth factor VEGF-C in human pancreatic cancer. Pancreas 2001 1.05
67 Attenuated ALK5 receptor expression in human pancreatic cancer: correlation with resistance to growth inhibition. Int J Cancer 1996 1.04
68 The helix-loop-helix protein Id2 is overexpressed in human pancreatic cancer. Cancer Res 1998 1.04
69 Smad6 suppresses TGF-beta-induced growth inhibition in COLO-357 pancreatic cancer cells and is overexpressed in pancreatic cancer. Biochem Biophys Res Commun 1999 1.03
70 Co-expression of heparin-binding EGF-like growth factor and related peptides in human gastric carcinoma. Int J Cancer 1996 1.03
71 Overexpression of platelet-derived growth factor (PDGF) B chain and type beta PDGF receptor in human chronic pancreatitis. Dig Dis Sci 1998 1.02
72 Galectin-1 and galectin-3 in chronic pancreatitis. Lab Invest 2000 1.02
73 KAI1, a new metastasis suppressor gene, is reduced in metastatic hepatocellular carcinoma. Hepatology 1998 1.01
74 Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: overexpression of epidermal growth factor receptor mRNA but not of c-erbB-2 and c-erbB-3. World J Surg 1999 1.01
75 Reduced KAI1 expression in pancreatic cancer is associated with lymph node and distant metastases. Int J Cancer 1998 1.01
76 Differential localization of transforming growth factor-beta isoforms in human gastric mucosa and overexpression in gastric carcinoma. Int J Cancer 1997 1.00
77 Increased cyclin D1 in human pancreatic cancer is associated with decreased postoperative survival. Oncology 1998 1.00
78 Growth inhibition of a human colorectal carcinoma cell line by interleukin 1 is associated with enhanced expression of gamma-interferon receptors. Cancer Res 1993 1.00
79 Molecular aspects of pancreatic cancer and future perspectives. Dig Surg 1999 1.00
80 Transforming growth factor-betas and their signaling receptors are coexpressed in Crohn's disease. Ann Surg 1999 0.99
81 Enhanced expression of TGF-betas and their receptors in human acute pancreatitis. Ann Surg 1998 0.97
82 Insulin receptors in isolated mouse pancreatic acini. Biochem Biophys Res Commun 1978 0.97
83 KAI1 is unchanged in metastatic and nonmetastatic esophageal and gastric cancers. Cancer Res 1998 0.96
84 Effects of enterally fed epidermal growth factor on the small and large intestine of the suckling rat. Regul Pept 1987 0.96
85 Growth factor receptors are differentially expressed in cancers of the papilla of vater and pancreas. Ann Surg 1999 0.96
86 Expression of a truncated EGF receptor is associated with inhibition of pancreatic cancer cell growth and enhanced sensitivity to cisplatinum. Int J Cancer 1996 0.96
87 Role of fibroblast growth factors and their receptors in pancreatic cancer and chronic pancreatitis. Pancreas 1998 0.96
88 AGR2 is a SMAD4-suppressible gene that modulates MUC1 levels and promotes the initiation and progression of pancreatic intraepithelial neoplasia. Oncogene 2012 0.95
89 p53 expression in human pancreatic cancer correlates with enhanced biological aggressiveness. Anticancer Res 1995 0.95
90 Binding of epidermal growth factor in rat pancreatic acini. Biochem Biophys Res Commun 1983 0.95
91 Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells. Clin Cancer Res 2001 0.95
92 Transfection of the type I TGF-beta receptor restores TGF-beta responsiveness in pancreatic cancer. Int J Cancer 1998 0.94
93 Divergent effects of epidermal growth factor and transforming growth factors on a human endometrial carcinoma cell line. Cancer Res 1987 0.94
94 Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine. Int J Cancer 2001 0.94
95 Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma. Cancer 1999 0.94
96 Cripto, a member of the epidermal growth factor family, is over-expressed in human pancreatic cancer and chronic pancreatitis. Int J Cancer 1994 0.94
97 Growth inhibition of human pancreatic carcinoma cells by transforming growth factor beta-1. Growth Factors 1993 0.93
98 Up-regulation of transforming growth factor (TGF)-beta receptors by TGF-beta1 in COLO-357 cells. J Biol Chem 1998 0.93
99 Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer. Cancer Res 2000 0.93
100 Binding and biological effects of tumor necrosis factor and gamma interferon in human pancreatic carcinoma cells. Pancreas 1990 0.93
101 Pancreatic cancer cells express interleukin-13 and -4 receptors, and their growth is inhibited by Pseudomonas exotoxin coupled to interleukin-13 and -4. Anticancer Res 1999 0.92
102 Coexpression of FAS and FAS-ligand in chronic pancreatitis: correlation with apoptosis. Pancreas 2000 0.92
103 Regulation of transforming growth factor-alpha mRNA expression in T3M4 human pancreatic carcinoma cells. Pancreas 1991 0.92
104 Alteration of fibroblast growth factor and receptor expression after acute pancreatitis in humans. Pancreas 1999 0.91
105 Effects of dietary manganese deficiency on rat pancreatic amylase mRNA levels. J Nutr 1990 0.91
106 A cholinergic antagonist identifies a subclass of muscarinic receptors in isolated rat pancreatic acini. J Pharmacol Exp Ther 1987 0.91
107 Ligand induced upregulation of the type II transforming growth factor (TGF-beta) receptor enhances TGF-beta responsiveness in COLO-357 cells. Pancreas 1999 0.90
108 Overexpression of activin A in stage IV colorectal cancer. Gut 2001 0.90
109 Altered expression and localization of the tight junction protein ZO-1 in primary and metastatic pancreatic cancer. Pancreas 2001 0.89
110 Insulin action in pancreatic acini from streptozotocin-treated rats. II. Binding of 125I-insulin to receptors. Am J Physiol 1981 0.89
111 Insulin-like growth factor I improves cardiovascular function and suppresses apoptosis of cardiomyocytes in dilated cardiomyopathy. Endocrinology 1999 0.89
112 A subgroup of patients with chronic pancreatitis overexpress the c-erb B-2 protooncogene. Ann Surg 1994 0.89
113 Presence of two signaling TGF-beta receptors in human pancreatic cancer correlates with advanced tumor stage. Dig Dis Sci 1997 0.88
114 Suppression of fibroblast growth factor receptor signaling inhibits pancreatic cancer growth in vitro and in vivo. Gastroenterology 1998 0.88
115 Fas and Fas-ligand expression in human pancreatic cancer. Ann Surg 2000 0.88
116 Expression of the multidrug-resistance 1 (MDR1) gene and prognosis in human pancreatic cancer. Pancreas 2000 0.88
117 Cloning of a variant epidermal growth factor receptor. Biochem Biophys Res Commun 1993 0.88
118 Tumor necrosis factor up-regulates gamma-interferon binding in a human carcinoma cell line. J Biol Chem 1990 0.88
119 Neoadjuvant cetuximab, twice-weekly gemcitabine, and intensity-modulated radiotherapy (IMRT) in patients with pancreatic adenocarcinoma. Ann Oncol 2012 0.88
120 Recycling of epidermal growth factor in a human pancreatic carcinoma cell line. Proc Natl Acad Sci U S A 1985 0.88
121 Concomitant over-expression of activin/inhibin beta subunits and their receptors in human pancreatic cancer. Int J Cancer 1998 0.88
122 Regulation of protein synthesis in normal and diabetic rat pancreas by cholecystokinin. Am J Physiol 1981 0.87
123 Amphiregulin antisense oligonucleotide inhibits the growth of T3M4 human pancreatic cancer cells and sensitizes the cells to EGF receptor-targeted therapy. Int J Cancer 1997 0.87
124 Manganese action on pancreatic protein synthesis in normal and diabetic rats. Am J Physiol 1983 0.87
125 Altered expression of insulin-like growth factor II receptor in human pancreatic cancer. Pancreas 1997 0.87
126 Differential regulation of fibroblast growth factor (FGF) receptor-1 mRNA and protein by two molecular forms of basic FGF. Modulation of FGFR-1 mRNA stability. J Biol Chem 1996 0.87
127 ErbB-4 mRNA expression is decreased in non-metastatic pancreatic cancer. Int J Cancer 1999 0.86
128 Altered expression of transforming growth factor-beta S in chronic renal rejection. Kidney Int 1996 0.85
129 TGF-beta-1 up-regulates cyclin D1 expression in COLO-357 cells, whereas suppression of cyclin D1 levels is associated with down-regulation of the type I TGF-beta receptor. Int J Cancer 1999 0.84
130 Absence of K-ras mutations in the pancreatic parenchyma of patients with chronic pancreatitis. Am J Surg 1997 0.83
131 Residual inhibition of epidermal growth factor binding by pancreatic secretagogues and phorbol ester in rat pancreas. J Cell Physiol 1985 0.83
132 Epidermal growth factor inhibits the proliferation of a human endometrial carcinoma cell line. J Clin Endocrinol Metab 1986 0.83
133 Stimulation of the glucose transport system in isolated mouse pancreatic acini by cholecystokinin and analogues. J Biol Chem 1979 0.83
134 Intratumoral delivery of shRNA targeting cyclin D1 attenuates pancreatic cancer growth. Cancer Gene Ther 2009 0.83
135 Epidermal growth factor receptor overexpression and trisomy 7 in a case of Barrett's esophagus. Dig Dis Sci 1990 0.83
136 Epidermal growth factor inhibits rat pancreatic cell proliferation, causes acinar cell hypertrophy, and prevents caerulein-induced desensitization of amylase release. Endocrinology 1989 0.82
137 Regulation of pancreatic protein synthesis by cholecystokinin and calcium. Am J Physiol 1982 0.82
138 Expression of the high molecular weight fibroblast growth factor-2 isoform of 210 amino acids is associated with modulation of protein kinases C delta and epsilon and ERK activation. J Biol Chem 2001 0.82
139 Upregulation of interferon-gamma binding by tumor necrosis factor and lymphotoxin: disparate potencies of the cytokines and modulation of their effects by phorbol ester. J Interferon Res 1991 0.82
140 The plasminogen activator/plasmin system is up-regulated after acute necrotizing pancreatitis in human beings. Surgery 1998 0.82
141 Receptors for cholecystokinin and insulin in isolated pancreatic acini: hormonal control of secretion and metabolism. Fed Proc 1981 0.82
142 Transforming growth factor betas and their receptors in human liver cirrhosis. Eur J Gastroenterol Hepatol 1998 0.82
143 Bak expression and cell death occur in peritumorous tissue but not in pancreatic cancer cells. J Gastrointest Surg 2000 0.81
144 Expression of the IIIc variant of FGF receptor-1 confers mitogenic responsiveness to heparin and FGF-5 in TAKA-1 pancreatic ductal cells. Int J Pancreatol 2001 0.81
145 Increased mdm2 expression and immunoreactivity in human pancreatic ductal adenocarcinoma. Int J Oncol 1994 0.80
146 Increased cyclin D1 expression in chronic pancreatitis. Pancreas 1998 0.80
147 Effects of 1-oleoyl-2-acetyl glycerol are distinct from those of phorbol ester in rat pancreatic acini. Life Sci 1987 0.80
148 Direct modulation of epidermal growth factor binding by cholecystokinin. Life Sci 1983 0.80
149 Effects of epidermal growth factor, insulin and insulin-like growth factor I on rat pancreatic acinar cells cultured in serum-free medium. Pancreas 1988 0.79
150 Differential distribution of human epidermal growth factor receptor family in acute pancreatitis. Dig Dis Sci 1995 0.79
151 Inhibition of epidermal growth factor binding in rat pancreatic acini by palmitoyl carnitine: evidence for Ca2+ and protein kinase C independent regulation. Cancer Res 1987 0.79
152 Islet growth factors: curing diabetes and preventing chronic pancreatitis? J Clin Invest 1993 0.79
153 Binding and processing of epidermal growth factor in Panc-I human pancreatic carcinoma cells. Life Sci 1985 0.79
154 Effect of lanthanum on pancreatic protein synthesis in streptozotocin-diabetic rats. Am J Physiol 1983 0.78
155 Basic fibroblast growth factor is a calcium-mobilizing secretagogue in rat pancreatic acini. Biochem Biophys Res Commun 1991 0.78
156 Insulin action in pancreatic acini from streptozotocin-treated rats. I. Stimulation of protein synthesis. Am J Physiol 1981 0.78
157 Overexpression of Smad2 and colocalization with TGF-beta1 in human pancreatic cancer. Dig Dis Sci 1999 0.78
158 Enhanced fibroblast growth factor 5 expression in stromal and exocrine elements of the pancreas in chronic pancreatitis. Gut 1998 0.78
159 Alterations in EGF binding to acini during pancreatic regeneration in the rat. Int J Pancreatol 1988 0.78
160 Alterations of pancreatic digestive enzyme content in the manganese-deficient rat. J Nutr 1987 0.77
161 Cytotoxic effects of TGF-alpha-Pseudomonas exotoxin A fusion protein in human pancreatic carcinoma cells. Pancreas 1996 0.77
162 Overexpression of transforming growth factor-alpha and epidermal growth factor receptor, but not epidermal growth factor, in exocrine pancreatic tumours in hamsters. Carcinogenesis 1996 0.77
163 Effects of manganese deficiency and dietary composition on rat pancreatic enzyme content. J Nutr 1987 0.77
164 Betacellulin, a member of the epidermal growth-factor family, is overexpressed in human pancreatic-cancer. Int J Oncol 1995 0.77
165 Dietary modulation of epidermal growth factor action in cultured pancreatic acinar cells of the rat. J Nutr 1986 0.77
166 Identification and characterization of muscarinic receptors in cultured human pancreatic carcinoma cells. Pancreas 1989 0.77
167 Processing of epidermal growth factor by suckling and adult rat intestinal cells. Am J Physiol 1986 0.77
168 Manganese action on protein synthesis in diabetic rat pancreas: evidence for a possible physiological role. J Nutr 1984 0.77
169 Long-term effect of tumor necrosis factor and gamma interferon in human pancreatic carcinoma cells. Int J Pancreatol 1990 0.77
170 COMP is selectively up-regulated in degenerating acinar cells in chronic pancreatitis and in chronic-pancreatitis-like lesions in pancreatic cancer. Scand J Gastroenterol 2003 0.77
171 Amphiregulin is a potent mitogen in human pancreatic-cancer cells - correlation with patient survival. Int J Oncol 1995 0.77
172 Epidermal growth factor binding is altered in pancreatic acini from diabetic rats. Life Sci 1984 0.77
173 Synthesis and biological evaluation of N alpha-hydroxysulfonyl-[Nle28,31]-CCK26-33. Life Sci 1986 0.77
174 Chronic pancreatitis: pathogenesis and molecular aspects. Ann Ital Chir 2000 0.76
175 Heparin-binding EGF-like growth factor expression and biological action in human pancreatic cancer cells. Int J Oncol 1996 0.76
176 microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-β actions. Oncogene 2017 0.75
177 A novel type I fibroblast growth factor receptor activates mitogenic signaling in the absence of detectable tyrosine phosphorylation of FRS2. J Biol Chem 2000 0.75
178 Modulation of cytosolic free calcium levels by extracellular phosphate and lanthanum. Proc Natl Acad Sci U S A 1987 0.75
179 Epidermal growth factor receptor expression in pancreatic lesions induced in the rat by azaserine. Br J Cancer 1996 0.75
180 Searching for the Holy Grail: the cause of diabetes. Lancet 1998 0.75
181 Single-strand conformation polymorphism analysis of the epidermal growth factor receptor at codon 497. Pancreas 1996 0.75
182 Manganese attenuates secretagogue-mediated phospholipid hydrolysis in AR42J cells. Life Sci 1989 0.75
183 Insulin-like growth factor II activates mitogenic signaling in pancreatic cancer cells via IRS-1. Int J Oncol 1996 0.75
184 Alteration of cholecystokinin-mediated phosphatidylinositol hydrolysis in pancreatic acini from insulin-deficient rats. Evidence for defective G protein activation. Diabetes 1991 0.75
185 Manganese-stimulated phosphorylation of a rat pancreatic protein: identity with elongation factor 2. Biochim Biophys Acta 1991 0.75
186 Effects of malnutrition and chronic reserpine treatment on pancreatic exocrine function. Pediatr Res 1986 0.75
187 Cholecystokinic activity of N alpha-hydroxysulfonyl-[Nle28,31]CCK26-33 analogues modified at the C-terminal residue. Int J Pept Protein Res 1988 0.75
188 Nicardipine as antihypertensive monotherapy: positive effects on quality of life. J Hum Hypertens 1991 0.75
189 Processing and transfer of epidermal growth factor in developing rat jejunum and ileum. Peptides 1991 0.75
190 [Molecular biology of pancreatic cancer: overexpression of fibroblast growth factors]. Chirurg 1994 0.75
191 Isolated pancreatic acini from suckling and weanling rats: changes in amino acid incorporation and carbachol-stimulated amylase secretion with age. Biol Neonate 1986 0.75
192 Effects of epidermal growth factor on growth response, morphology, and invasive potential of human endometrial carcinoma cell line RL95-2. Cancer Commun 1991 0.75
193 Manganese modulates protein phosphorylation in the rat pancreas: in vitro evidence for cation selective regulation. Pancreas 1990 0.75